For the Inventor, By the Inventor

Enter assignee name

Cambridge, United Kingdom

Nxera Pharma UK Limited

USPTO Granted Patents = 17

EPO Patents = 23

Trademarks = 1

Forward Citations = 0

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Miles Stuart Congreve (14 out of 96 patents)

Giles Albert Brown (13 out of 68 patents)

Nigel Alan Swain (8 out of 9 patents)

4. Benjamin Gerald Tehan (6 out of 60 patents)

5. John Andrew Christopher (5 out of 24 patents)

6. Sarah Joanne Bucknell (5 out of 13 patents)

7. Francesca Deflorian (5 out of 13 patents)

8. Jonathan Stephen Mason (4 out of 16 patents)

9. Mark Pickworth (4 out of 39 patents)

10. Stephen Paul Watson (4 out of 4 patents)

11. Michael Alistair O'brien (4 out of 4 patents)

12. Julie Elaine Cansfield (3 out of 29 patents)

13. Stephen Philippe Andrews (3 out of 7 patents)

14. Christine Mary Richardson (2 out of 6 patents)

15. Anil Patel (2 out of 3 patents)

17 patents: Sort by Forward Citations

1. 12729189 - GPR52 modulator compounds (2026-09-08),

2. 12655120 - GPR52 modulator compounds (2026-06-16),

3. 12552799 - Triazolone compounds (2026-02-17),

4. 12528815 - 5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer (2026-01-20),

5. 12492174 - Morpholine-3-carboxamide derivatives as prostaglandin E2 receptor 4 (EP4) agonists for the treatment of gastrointestinal and pulmonary diseases (2025-12-09),

6. 12441777 - GLP-1 receptor antagonists (2025-10-14),

7. 12415795 - 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators (2025-09-16),

8. 12344621 - CGRP antagonist compounds (2025-07-01),

9. 12331029 - Orexin 1 receptor antagonists (2025-06-17),

10. 12291512 - Oxime compounds as agonists of the muscarinic Mand/or Mreceptor (2025-05-06),

11. 12240825 - Oxexin 1 receptor antagonists (2025-03-04),

12. 12234227 - Pyrazole derivatives as H4 antagonist compounds (2025-02-25),

13. 12227521 - CGRP antagonist compounds (2025-02-18),

14. 12215099 - Quinolinone and benzoxazine derivatives as muscarinic Mand/or Mreceptor agonists (2025-02-04),

15. 12202843 - Muscarinic receptor agonists (2025-01-21),

Nxera Pharma UK Limited is a biotechnology company based in Cambridge, specializing in the development of innovative therapeutic solutions. The organization focuses on advancing drug discovery and formulation technologies, particularly in the fields of oncology and rare diseases. With a commitment to addressing unmet medical needs, Nxera Pharma leverages cutting-edge research and collaborative partnerships to enhance treatment options and improve patient outcomes in the global healthcare landscape.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

17 Patents

#64 in Cambridge

#1,058 in United Kingdom

#35,887 in the World

Cambridge, United Kingdom

Nxera Pharma UK Limited

Forward Citations = 0

31 inventors:

Miles Stuart Congreve (14 out of 96 patents)

Giles Albert Brown (13 out of 68 patents)

Nigel Alan Swain (8 out of 9 patents)

4. Benjamin Gerald Tehan (6 out of 60 patents)

5. John Andrew Christopher (5 out of 24 patents)

Please report any incorrect information to [email protected]

Loading…